Pholcodine-induced Stevens-Johnson syndrome in a patient with COVID-19.

Bulat, Vedrana; Likic, Robert; Pondeljak, Nives; Azdajic, Marija Delas

Bulat, Vedrana; Likic, Robert; Pondeljak, Nives; Azdajic, Marija Delas.

Bulat V; Department of Dermatology and Venereology, University Hospital Centre Sestre Milosrdnice, Zagreb, Croatia.
Likic R; Department of Internal Medicine, Division of Clinical Pharmacology and Therapeutics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia robert.likic@mef.hr.
Pondeljak N; Department of Dermatology and Venereology, University Hospital Centre Sestre Milosrdnice, Zagreb, Croatia.
Azdajic MD; Department of Dermatology and Venereology, University Hospital Centre Sestre Milosrdnice, Zagreb, Croatia.

Postgrad Med J ; 98(1161): 499-500, 2022 07.

Article in English | MEDLINE | ID: covidwho-1195857

Subject(s)

COVID-19; Stevens-Johnson Syndrome; Codeine/analogs & derivatives; Humans; Morpholines; Stevens-Johnson Syndrome/diagnosis; Stevens-Johnson Syndrome/etiology

Keywords

COVID-19; adverse events; clinical pharmacology; infectious diseases & infestations

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Stevens-Johnson Syndrome / COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: Postgrad Med J Year: 2022 Document Type: Article Affiliation country: Postgradmedj-2021-139892

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google